Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating myeloablative allogeneic stem cell transplantation with a naive T-cell depleted peripheral blood graft…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match [Phase 2]
Phase 2 trial evaluating pooled unrelated donor umbilical cord blood transplant for hematologic malignancies requiring allogeneic stem cell …
-
EMA guidance · 2013-11-22European Medicines Agency recommends changes in use of leukaemia medicine Iclusig (ponatinib) in order to minimise risk of blood clots
EMA recommends changes in how ponatinib (Iclusig) is used to reduce the risk of blood clots in leukemia treatment.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate [Phase 1]
Phase 1 trial investigating gene-expression changes during chemotherapy in newly diagnosed acute myeloid leukemia patients treated with Chol…
-
CLINICAL_TRIALS research · 2013-11-19Clinical Trial Update: Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML [Phase 2]
Phase 2 clinical trial update evaluating targeted busulfan and fludarabine in pediatric acute myeloid leukemia undergoing hematopoietic stem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating total-body irradiation plus stem cell transplantation and white blood cell infusion in older patients with…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Prevention of Left Ventricular Dysfunction During Chemotherapy [Phase 3]
Phase 3 clinical trial update focusing on preventing left ventricular dysfunction during chemotherapy in patients with hematologic cancers.
-
CLINICAL_TRIALS research · 2013-11-15Clinical Trial Update: RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML
This clinical trial update investigates whether RFC and MTHFR SNPs and hENT1-dCK expression serve as prognostic factors in acute lymphoblast…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 3]
This Phase 3 clinical trial compares cytarabine alone versus cytarabine with VNP40101M in relapsed acute myeloid leukemia. The study has com…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 3]
Phase 3 trial evaluating interleukin-2 plus histamine dihydrochloride in acute myeloid leukemia has completed.
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Phase 3]
Phase 3 clinical trial update evaluating chemotherapy with or without monoclonal antibody therapy in patients with refractory or relapsed ac…
-
CLINICAL_TRIALS withdrawal · 2013-11-06Clinical Trial Update: A Phase 2 Study of Tandutinib in Patients With Newly Diagnosed Acute Myelogenous Leukemia Who Are Considered Ineligible For or Who Decline Treatment With Standard Induction Therapy [Phase 1, Phase 2]
A Phase 1/2 study of tandutinib in newly diagnosed acute myeloid leukemia patients who are ineligible for or decline standard induction ther…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [NA]
Status update on a clinical trial evaluating antithymocyte globulin and cyclosporine to prevent graft-versus-host disease in patients with a…
-
CLINICAL_TRIALS research · 2013-10-31Clinical Trial Update: Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival [NA]
A clinical trial update describing a program to evaluate geriatric intervention aimed at improving functional status, quality of life, and s…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction [Phase 2]
Phase 2 trial updating on a combination regimen of clofarabine, idarubicin, and cytarabine for induction in acute myeloid leukemia; study co…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [Phase 3]
Phase 3 trial evaluating low-dose or high-dose conditioning regimens before peripheral blood stem cell transplantation in patients with myel…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function [Phase 1]
Phase 1 pharmacokinetics and safety study of azacitidine in cancer patients with and without impaired renal function has completed. Results …
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial update of cladribine, cytarabine, and imatinib mesylate in refractory or relapsed acute myeloid leukemia or blastic phase chro…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 clinical trial evaluating the combination of flavopiridol, cytarabine, and mitoxantrone …
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes [Phase 1]
A Phase 1 study evaluating the combination of vorinostat with idarubicin in patients with relapsed or refractory leukemia or myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes [Phase 1]
Phase 1 trial evaluating Tanespimycin in combination with Cytarabine in adults with relapsed or refractory acute myeloid leukemia, acute lym…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes [Phase 1]
Phase 1 trial of the combination therapy 7-Hydroxystaurosporine and perifosine in adults with relapsed or refractory acute leukemias, chroni…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating decitabine in combination with valproic acid for adults with refractory or relapsed acute myeloid leukemia or previ…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 1]
Phase 1 trial of decitabine in patients with myelodysplastic syndromes or acute myeloid leukemia; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia [Phase 1]
A Phase 1 trial evaluating flavopiridol with cytarabine and mitoxantrone in adults with relapsed or refractory acute leukemia; the study has…